AI expert Desidi Narsimha Reddy launches AYURA, a voice-based healthcare platform
Desidi Narsimha Reddy, a Hyderabad-based AI and data executive, has launched Ayura, a voice-first multilingual healthcare platform designed to make medical services more affordable and accessible.
Published Date - 24 June 2026, 12:21 AM
Hyderabad: Desidi Narsimha Reddy, a data and artificial intelligence executive with expertise in analytics, data governance and AI-driven transformation, announced the launch of “AYURA”, a voice-first, multilingual AI healthcare platform aimed at making healthcare more affordable and accessible.
AYURA enables users to describe their symptoms through natural voice interactions and receive immediate triage guidance, care coordination support, appointment assistance and information on treatment options. It also provides information on treatment options available across different regions, helping users compare healthcare services and costs.
Speaking about the initiative in a statement, Narsimha Reddy said the platform was built to empower patients and families to make informed healthcare decisions without the fear of excessive medical expenses.
“AYURA is built to reduce cost fear, eliminate dead-end decisions and provide clarity and continuity, especially for families in South Asia and diaspora communities who face literacy, language or access challenges,” he said.
A notable aspect of the platform is its focus on developmental and neurological conditions such as autism and Attention Deficit Hyperactivity Disorder (ADHD). Reddy said this emphasis was inspired by his personal experience as a parent.
Reddy holds a postgraduate degree in Machine Learning and Artificial Intelligence from Purdue University and an MBA in Finance and Information Systems from Mahatma Gandhi University, India.
Through Soniks Consulting LLC, he advises organisations on data strategy, artificial intelligence, machine learning and enterprise performance management. Among his innovations is an AI-based device developed to measure nerve damage caused by diabetic neuropathy.